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Approach to Infants Born at 22 to 24 Weeks’ Gestation:
Relationship to Outcomes of More-Mature Infants
WHAT’S KNOWN ON THIS SUBJECT: Although morbidity-free
survival for preterm infants has remained constant in US NICUs
when assessed collectively, morbidity-free survival differs among
centers. Center-specific practices before, at, or after delivery
might affect outcomes of the most premature infants.
WHAT THIS STUDY ADDS: Our findings suggest that the approach
taken to infants at the limits of viability is associated with
outcomes of more-mature infants. Identifying centers with higher
survival and lower morbidity might lead to identification of key
practices to improve morbidity-free survival.
abstract
OBJECTIVE: We sought to determine if a center’s approach to care of premature
infants at the youngest gestational ages (22–24 weeks’ gestation) is associated
with clinical outcomes among infants of older gestational ages (25–27 weeks’
gestation).
METHODS: Inborn infants of 401 to 1000 g birth weight and 22 0/7 to 27 6/7
weeks’ gestation at birth from 2002 to 2008 were enrolled into a prospectively
collected database at 20 centers participating in the Eunice Kennedy Shriver
National Institute of Child Health and Human Development Neonatal Research
Network. Markers of an aggressive approach to care for 22- to 24-week infants
included use of antenatal corticosteroids, cesarean delivery, and resuscitation.
The primary outcome was death before postnatal day 120 for infants of 25
to 27 weeks’ gestation. Secondary outcomes were the combined outcomes
of death or a number of morbidities associated with prematurity.
RESULTS: Our study included 3631 infants 22 to 24 weeks’ gestation and 5227
infants 25 to 27 weeks’ gestation. Among the 22- to 24-week infants, use of
antenatal corticosteroids ranged from 28% to 100%, cesarean delivery from
13% to 65%, and resuscitation from 30% to 100% by center. Centers with
higher rates of antenatal corticosteroid use in 22- to 24-week infants had
reduced rates of death, death or retinopathy of prematurity, death or late-onset
sepsis, death or necrotizing enterocolitis, and death or neurodevelopmental
impairment in 25- to 27-week infants.
CONCLUSIONS: This study suggests that physicians’ willingness to provide
care to extremely low gestation infants as measured by frequency of use of
antenatal corticosteroids is associated with improved outcomes for more-
mature infants. Pediatrics 2012;129:e1508–e1516
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Recent studies have demonstrated little
progress in reducing the mortality and
morbidities associated with extremely
preterm birth.1,2 Although morbidity-
free survival for preterm infants has
remained constant in US NICUs when
assessed collectively, morbidity-free
survival differs among centers, even af-
ter adjustment for maternal and infant
demographic factors.3 Center-specific
practices before, at, or after delivery
might affect outcomes of the most pre-
mature infants.
Physicians and other health care pro-
viders inNICUswhere resuscitationand
provision of intensive care for infants at
the border of viability (22–24 weeks’
gestation) is routine might develop
center-specific practices, protocols, and
expertise from treating the most im-
mature infants that result in improved
outcomes among more-mature infants
(25–27weeks’ gestation) for whom there
is consensus for an aggressive inten-
sive care approach. Whether center ap-
proach to caring for the smallest and
least-mature infants translates into
improved rates of survival andmorbidity-
free survival for more-mature infants is
unknown. Markers of a more aggres-
sive approach toward the care of 22-
to 24-week infants include active in-
terventions by obstetricians (antenatal
corticosteroids and cesarean deliveries
for fetal indications) and neonatologists
(delivery room resuscitation).
The Eunice Kennedy Shriver National
Institute of Child Health and Human
Development (NICHD) Neonatal Research
Network (NRN) Generic Database (GDB)
provides a unique opportunity to better
identify and characterize center practi-
ces that are associated with variations
in survival and other common morbid-
ities in extremely low gestation infants.
In this analysis, we tried to answer the
following question: In centers where
physicians take an aggressive approach
to the care of premature infants at the
youngest gestational ages, are clinical
outcomes for infants of older gesta-
tional ages better than in centers where
a less aggressive approach is taken
with younger gestation infants?4,5 We
hypothesized that mortality and mor-
bidities (severe retinopathy of pre-
maturity [ROP], late-onset sepsis [LOS],
severe intraventricular hemorrhage
[IVH], periventricular leukomalacia [PVL],
necrotizing enterocolitis [NEC], broncho-
pulmonary dysplasia [BPD], and neuro-
developmental impairment [NDI]) among
infants at 25 to 27 weeks’ gestation at
NRN centers would be lower in centers
with the highest rates of antenatal
corticosteroid use, cesarean delivery,




The NICHD NRN is a consortium of ter-
tiary NICUs. The network’s GDB pro-
spectively collects data on all extremely
low birth weight (ELBW; 401–1000 g)
infants born at participating centers
or transferred to participating centers
in the first 14 postnatal days. Trained
research personnel collect maternal
demographic, pregnancy, and delivery
data until death, discharge, or postnatal
day 120. Inborn infants entered into the
database between January 1, 2002, and
December 31, 2008, who were 22 0/7
to 27 6/7 weeks’ gestation and 401 to
1000 g at birth were included in the
analysis. Infants with major congenital
or chromosomal anomalies were ex-
cluded.
Clinical Methods
Definitions of terms and diagnoses
were guided by the NICHD NRN GDB
manual of operations. Gestational age
was determined as the best obstetric
estimate based on ultrasound and/or
date of the last menstrual period, or, if
the obstetric estimate was unavailable,
as the best neonatologist estimate.
Resuscitation was defined as intuba-
tion in the delivery room or survival
.24 hours. Only severe ROP (re-
quiring laser surgery) was consid-
ered in this analysis. LOS was defined
by a positive blood culture obtained
after postnatal day 3 in the presence of
clinical signs compatible with septice-
mia and $5 days of antibiotic treat-
ment.6 Blood cultures positive for
organisms generally considered con-
taminants, including Corynebacterium
(or “diphtheroids”), Propionibacterium,
and Penicillium, were excluded. IVH
was graded by using the method of
Papile et al,7 with severe IVH defined
as grade 3 or 4 IVH for this analysis. PVL
was defined as cystic PVL. NEC was
defined as $stage 2 according to the
modified Bell criteria.8 BPD was de-
fined by the use of supplemental oxy-
gen at 36 weeks’ postmenstrual age or
at the time of discharge home. NDI was
defined as impairment by the Bayley
Scales of Infant Development II (2004–
2006) and included neurologic im-
pairment (moderate-to-severe cerebral
palsy with gross motor function clas-
sification system [GMFCS] level $2),
developmental impairment (mental
developmental index ,70 or psycho-
motor developmental index ,70), vi-
sion impairment (,20–200 in both
eyes), and/or hearing impairment (bi-
lateral amplification for permanent
hearing loss). Impairment by Bayley
Scales of Infant Development III (2006–
2008) included neurologic impairment
(moderate-to-severe cerebral palsy
with GMFCS impairment $ level 2),
developmental impairment (cognitive
score,70 or GMFCS$ level 2), vision
impairment (,20–200 in both eyes),
and/or hearing impairment (perma-
nent hearing loss that does not permit
the child to understand the direc-
tions of the examiner and communi-
cate despite amplification). NDI was
assessed during a comprehensive
neurodevelopmental evaluation at 18
to 22 months’ adjusted age.
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Statistical Analysis
The primary outcome for this studywas
death before postnatal day 120 for
infants of 25 to 27 weeks’ gestation.
Secondary outcomes were death or
ROP, death or LOS, death or severe IVH,
death or PVL, death or BPD, and death
or NDI for infants of 25 to 27 weeks’
gestation. We summarized demographic
variables and outcomes in the 2 gesta-
tional age cohorts.
We used random effects multiple lo-
gistic regression to examine the re-
lationship between center rates of
antenatal corticosteroid use, cesarean
delivery, and resuscitation for 22- to
24-week infants and clinical outcomes
in 25- to 27-week infants.9,10 Separate
models were used for each of the 3
predicting factors. Individual-level risk
factors in the model included sex, birth
weight, gestational age, race, maternal
education level, and type of insurance,
as well as antenatal corticosteroid
use for 25- to 27-week infants. Be-
cause the variability of interventions
among 23-week infants was greater
than that observed in the 22- and 24-
week infants, we conducted a sec-
ondary analysis limiting the predictor
variables to rates of interventions (an-
tenatal corticosteroid use, cesarean
deliveries, and resuscitation) among 23-
week infants controlling for the same
variables.
We conducted sensitivity analyses for
our results by repeating the analysis
after removing the centers with the
highest and lowest rates of inter-
vention. Because of the concern that
aggressive measures in 22- to 24-week
infants would lead to poor outcomes in
this group, we repeated the analysis to
examine the effect of interventions
among 22- to 24-week infants on mor-
tality in this population. In this analysis,
we controlled for infant sex, birth
weight, gestational age, maternal edu-
cation level, insurance type, race, and
antenatal corticosteroid exposure at
the individual level. Infants lost to
follow-up at 18 to 22 months’ adjusted
age were treated asmissing in the final
models.
All data were analyzed by using SAS
version 9.2 (SAS Inc, Cary, NC) at RTI
International, the data coordinating
center for the NRN. The institutional
review board at each NRN center and at
RTI approved the inclusion of data in the
GDB.
RESULTS
The study cohort included 8858 ELBW
infants born at 20 centers of the NICHD
NRN; 3631 (41%) infantswere born at 22
to 24 weeks’ gestation, and 5227 (59%)
infants were at 25 to 27 weeks’ gesta-
tion (Table 1).
Overall, 3191 (36%) infants died. As
expected, death was much more
common among infants at 22 to 24
weeks (61%) than among those at 25
to 27 weeks (19%) (Table 2). The
combined outcomes of death or
morbidity for each of ROP, LOS, severe
IVH, PVL, NEC, and BPD were higher
among 22- to 24-week infants com-
pared with 25- to 27-week infants
(Table 2).
Outcomes for 25- to 27-week infants
varied by center (Fig 1). Only 5% of 25-
to 27-week infants died at the center
with the lowest mortality compared
with 38% at the center with the high-
est mortality. Death or NEC ranged
from 7% at the lowest center to 47% at
the highest center, and, similarly,
death or BPD ranged from 33% to 89%.
By using Pearson correlation, we
found a statistically significant asso-
ciation between outcomes for 22- to
24-week and 25- to 27-week infants
within centers for both death and
each of the combined outcomes of
death and ROP, LOS, severe IVH, PVL,
NEC, and BPD (P , .001).
There were wide center variations in
obstetrical and neonatal interventions
among infants at 22 to 24 weeks (Fig 2
A–C). Use of antenatal corticosteroids
ranged from 28% to 100%, cesarean
deliveries from 13% to 65%, and re-
suscitation from 30% to 100%. Com-
pared with infants born at 22 to 24
weeks’ gestation, infants born at 25 to
27 weeks’ gestation were more likely
to have received antenatal cortico-
steroids (87% vs 62%), be delivered by
cesarean delivery (70% vs 39%), and
be resuscitated at birth (99% vs 75%).
Infants born at 24 weeks had active
interventions nearly as often as those
born at 25 to 27 weeks (Fig 3 A–C). Few
infants born at 22 weeks received an-
tenatal corticosteroids (12%), were
delivered via cesarean delivery (7%),
or were resuscitated at birth (20%).
TABLE 1 Neonatal Characteristics by






401–500 634 (18) 183 (4)
501–750 2666 (73) 1757 (34)
751–1000 331 (9) 3287 (63)
Female sex 1658 (46) 2614 (50)
SGA at birth 162 (4) 564 (11)
Race
White 1884 (52) 2796 (54)
African American 1527 (42) 2160 (41)
Other 178 (5) 235 (5)
Antenatal corticosteroids 2263 (62) 4551 (87)
SGA, small for gestational age.
TABLE 2 Unadjusted Neonatal Outcomes by





Death 2219 (61) 972 (19)
ROP 337 (9) 306 (6)
LOS 1147 (32) 1839 (35)
IVH 686 (19) 740 (14)
PVL 141 (4) 243 (5)
NEC 328 (9) 578 (11)
BPD 990 (27) 2038 (39)
NDI 500 (42) 878 (26)
Death/ROP 2549 (70) 1272 (24)
Death/LOS 3014 (83) 2520 (48)
Death/IVH 2515 (69) 1446 (28)
Death/PVL 2311 (64) 1163 (22)
Death/NEC 2389 (66) 1359 (26)
Death/BPD 3188 (88) 2956 (57)
Death/NDI 2806 (77) 1999 (38)
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By using Pearson correlation, we ob-
served statistically significant as-
sociations between aggressive center
practices (use of antenatal cortico-
steroids, cesarean deliveries, and re-
suscitation) within a center for 22- to
24-week infants (all correlation coef-
ficients .0.74 and P , .001), as well
as significant associations between ag-
gressive center practices for 22- to 24-
week infants and 25- to 27-week infants
within centers.
Adjusted random effects logistic re-
gression modeling demonstrated that,
for every 10% increase in center rate of
antenatalcorticosteroiduse in22- to24-
week infants, outcomes improved in 25-
to 27-week infants for death, death or
ROP, death or LOS, death or NEC, and
death or NDI (Table 3). Specifically,
a 10% increase in a center’s antenatal
corticosteroid usage among 22- to 24-
week infants was associated with
a 15% reduction in the odds of death by
120 days among 25- to 27-week infants.
None of the outcomes in 25- to 27-week
infants were statistically different based
on rate of cesarean delivery and re-
suscitation in 22- to 24-week infants;
however, for centers with higher rates
of cesarean delivery and resuscitation
among infants at 22 to 24 weeks, 14
(88%) of 16 of the outcomes for 25- to
27-week infants had point estimates
with improved outcomes, although
these did not reach statistical signifi-
cance. Limiting the analysis to inter-
ventions among infants born at 23
weeks’ gestational age, where there
was most variation in use of antenatal
corticosteroids, cesarean deliveries,
and resuscitation, we observed similar
results; an increase in center use of
antenatal corticosteroids in the 22- to
24-week infants was associated with
decreased risk of death, death or ROP,
death or LOS, death or NEC, and death
or NDI among 25- to 27-week infants.
A sensitivity analysis performed by re-
moving the centerswith thehighest and
lowest rates of intervention produced
similar effects for center rates of an-
tenatal steroid use, cesarean delivery,
and resuscitation on death (odds ratio
[OR] = 0.89 [95% confidence interval
(CI): 0.73, 1.09]; OR = 1.00 [0.74, 1.35];
OR = 0.93 [0.77, 1.12], respectively).
Repeating the analysis to examine the
effect of interventions among 22- to 24-
week infants on mortality in this pop-
ulation, we found that increased center
rates of antenatal corticosteroid use,
cesarean deliveries, and resuscitation
among 22- to 24-week infants were
associated with lower mortality among
22- to 24-week infants (OR = 0.72 [95%
CI: 0.60, 0.87]; OR=0.67 [0.50, 0.89]; and
OR = 0.77 [0.64, 0.92], respectively). To
account for potential differences in
the outcomes of the 25- to 27-week
group associated with cesarean de-
livery use in this population, we re-
peated the analysis with the addition
of a covariable for cesarean delivery
in individual 25- to 27-week infants.
The association between center use of
antenatal corticosteroids and mor-
tality in the 22- to 24-week infants was
still statistically significant (OR = 0.85
[0.74, 0.97]).
DISCUSSION
Center differences are an important
factor for outcomes in premature
infants. Although recent multicenter
cohorts demonstrated static outcomes
for premature infants, there were
striking differences in mortality and
morbidity among individual centers.11,12
These differences were present after
accounting for center differences in
confounding factors known to affect
clinical outcomes, such as birth weight,
gestational age at birth, antenatal cor-
ticosteroid use, and sex.11 A review of
infants at 22 to 28 weeks’ gestation and
,1500 g birth weight from 2003 to
2007 found that morbidity-free survival
ranged from 7% to 50% across NICHD
NRN centers.2 Multivariable modeling
of GDB data found the ratio of observed
to expected rate of adverse outcomes
ranged from 0.60 to 1.38 for death and
0.75 to 1.23 for death or profound NDI
by center (www.nichd.nih.gov/neo-
natalestimates).1 In a previous study,
we compared multiple logistic re-
gression and neural network models
for predicting death for ELBW infants
at 5 time points with cumulative data
sets.13 Center was highly significant
and important in all models in which it
was entered. The magnitude of this
center variation in outcome is much
larger than the effect sizes of nearly
all proven interventions, such as sur-
factant, continuous positive airway
pressure, or vitamin A.14–16
FIGURE 1
Center variation in outcomes for 25- to 27-week infants (median, range).
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Our study sought to determine whether
aggressive obstetrical and delivery room
practices in caring for the most pre-
mature infants (22–24weeks’ gestation)
were associated with improved out-
comes for more-mature infants (25–
27 weeks’ gestation). We limited the
outcomes analyzed to death and the
combined outcomes of death and com-
monmorbidities of prematurity. This was
done to avoid the pitfall of comparing
rates of individual outcomes without
accounting for death as a competing
outcome. NICUs in which health care
providers routinely administer antenatal
corticosteroids, perform a cesarean
delivery if indicated, and resuscitate
infants at the edge of viability might
develop center-specific practices and
protocols for these infants that, when
implemented in more-mature infants,
lead to improved outcomes in the more-
mature cohort. In addition, physicians
and other personnel at these centers
might develop more seamless team-
work and skill at early management of
extremely premature infants because of
experience resuscitating and stabilizing
these infants. Our studywas limited, as it
is a retrospective cohort study. Although
our study was limited by the uncertain-
ties inherent in determining gestational
age, the estimates used in our analyses
are the same as those used by clinicians
discussing potential outcomes of pre-
term infants with families.17–19
Antenatal corticosteroid use is known to
improve clinical outcomes in infants
$26 weeks’ gestation at birth.20 In
a recent analysis of NICHD NRN data,
investigators observed a similar asso-
ciation between exposure to antenatal
corticosteroid use among 22- to 25-
week infants on the combined outcome
of death or NDI (OR = 0.58 [95% CI: 0.42,
0.80])21; however, these results may be
biased by the selective use of cortico-
steroids in pregnancies with other fa-
vorable prognostic factors. Current
guidelines advise administering ante-
natal corticosteroids to women at high
risk of delivery between 24 and 34
weeks’ gestation22; further study is
needed to evaluate administration of
antenatal corticosteroids to infants
,24 weeks’ gestation. We repeated our
analysis to examine the effect of
interventions among 22- to 24-week
FIGURE 2
Interventions in 22- to 24-week infants by center. A, Antenatal corticosteroid use by center; B, cesarean
delivery rate by center; C, resuscitation rate by center.
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infants on mortality in 22- to 24-week
infants to ensure that aggressive
measures were not associated with
poor outcomes in this group. In our
cohort, increased center rates of
antenatal corticosteroid use, cesarean
delivery, and resuscitation among 22- to
24-week infants were associated with
lower mortality among 22- to 24-week
infants.
Despite evidence that delivery via
cesarean delivery imparts a survival
benefit for infants at 22 to 25 weeks’
gestation,23 some obstetricians do not
routinely use electronic fetal moni-
toring or consider cesarean delivery
for fetal indications for infants at
,24 weeks’ gestation.24 The benefi-
cial impact of cesarean delivery on
survival must be weighed against the
risk of long-term morbidities in the
surviving infant and the potential
effects of cesarean delivery on ma-
ternal health.25
The decision to resuscitate infants at
22 to 24 weeks’ gestation is contro-
versial and varies greatly by neo-
natologist and by center.9 We noted
that for each of the interventions, 1
center was strikingly less aggressive
than the others. In our sensitivity
analysis, performed by removing the
centers with the highest and lowest
rates of intervention, the association
between antenatal steroid use and
survival was no longer statistically
significant, but the point estimate was
nearly identical (0.89 vs 0.84), sug-
gesting that the loss of statistical
significance was caused by the re-
duced sample size available for the
sensitivity analysis. Among NICHD
NRN centers, intensive care is rou-
tinely administered to infants $25
weeks’ gestation. Decisions to inter-
vene at earlier gestational ages vary
among centers but are typically made
after discussions between the pa-
rents and medical staff based on
evidence that does not take into ac-
count the wide variations in center
outcomes.26
Our findings suggest that aggressive
clinical management of pregnancies
and infants at the limits of viability, as
measured by use of antenatal steroids,
is associated with improved outcomes
in more-mature infants, for whom con-
sensus supports universal use of an
aggressive intensive care approach.
FIGURE 3
Interventions by gestational age. A, Antenatal corticosteroid use by gestational age; B, cesarean delivery
rate by gestational age; C, resuscitation rate by gestational age.
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We did not observe a relationship be-
tween rates of cesarean delivery and
resuscitation of the most premature
infants and outcomes of more-mature
infants.
Identifying centers with consistently
higher survival and less morbidity
among the lowest gestational age
infants might lead to identification of
key practices that improve the chance
of morbidity-free survival. These prac-
tices might form the basis for inter-
vention trials to identify the extent
to which the practices translate into
better outcomes in other centers. In-
creased center use of antenatal cor-
ticosteroids among 22- to 24-week
infants was associated with improved
outcomes for 25- to 27-week infants,
including lower rates of death or NDI.
Expertise developed and intangible
lessons learned from caring for the
most premature infants might translate
into improved outcomes for more-
mature infants. The challenge is to sys-
tematicallydeterminethecenter-specific
practicesaccounting for thevariations in
outcomes among the extremely low
gestational age infants and consider
these results when making program-
matic decisions about obstetrical and
neonatal interventions at the lowest
gestational ages.
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Death 0.85 (0.74, 0.97)a 0.84 (0.68, 1.05) 0.89 (0.78, 1.02)
Death or ROP 0.82 (0.71, 0.95)a 0.84 (0.67, 1.06) 0.88 (0.76, 1.01)
Death or LOS 0.81 (0.73, 0.90)a 0.83 (0.69, 1.00) 0.89 (0.79, 1.01)
Death or severe IVH 0.94 (0.81, 1.08) 0.93 (0.76, 1.09) 0.96 (0.84, 1.10)
Death or PVL 0.91 (0.81, 1.04) 0.91 (0.76, 1.09) 0.94 (0.84, 1.06)
Death or NEC 0.83 (0.73, 0.96)a 0.83 (0.67, 1.03) 0.89 (0.78, 1.02)
Death or BPD 0.99 (0.75, 1.29) 1.16 (0.80, 1.69) 1.00 (0.78, 1.29)
Death or NDI 0.88 (0.78, 0.98)a 0.91 (0.76, 1.09) 0.95 (0.85, 1.07)
a P , .05.
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